田畑 耕史郎 (タバタ コウシロウ)

総合イノベーション創発機構ワクチン研究開発拠点特任講師

研究者基本情報

■ 学位
  • 博士(獣医学), 北海道大学, 2023年03月
  • 修士(薬科学), 東京理科大学, 2019年03月
■ URL
researchmap URLホームページURL■ ID 各種
研究者番号
  • 70980837
ORCID IDJ-Global ID■ 研究キーワード・分野
研究分野
  • ライフサイエンス, ウイルス学, ワクチン学

経歴

■ 経歴
経歴
  • 2026年11月 - 現在
    北海道大学, ワクチン研究開発拠点, 特任講師
  • 2023年04月 - 2026年10月
    北海道大学, ワクチン研究開発拠点, 特任助教, 日本国
  • 2020年04月 - 2023年03月
    日本学術振興会, 特別研究員(DC1), 日本国
学歴
  • 2019年04月 - 2023年03月, 北海道大学, 大学院国際感染症学院, 博士課程, 人獣共通感染症国際共同研究所, 日本国
  • 2017年04月 - 2019年03月, 東京理科大学, 薬学研究科, 修士課程, 日本国
  • 2013年04月 - 2017年03月, 東京理科大学, 薬学部, 生命創薬科学科, 日本国

研究活動情報

■ 受賞
  • 2024年09月, 日本生体防御学会, 日本生体防御学会優秀発表賞
    田畑 耕史郎
  • 2023年12月, 日本抗体学会, ポスター発表優秀賞
    田畑耕史郎
■ 論文
  • Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions
    Hideo Fukuhara; Hisham M. Dokainish; Shunsuke Kita; Koshiro Tabata; Akira Takasu; Juha T. Huiskonen; Yuki Anraku; Tomo Nomai; Taiyo Someya; Toshiya Senda; David I. Stuart; Michihito Sasaki; Yasuko Orba; Yasuhiko Suzuki; Hirofumi Sawa; Katsumi Maenaka
    Protein Science, 2026年12月
    研究論文(学術雑誌)
  • The NS4B A119T mutation of dengue virus 2 confers adaptation to mammalian cells and increased pathogenicity in AG129 mice
    Koshiro Tabata; Yukari Itakura; Kentaro Uemura; Malala Mulavu; Miho Yamashita; Takako Matsushita; Shinji Kusakabe; Shinsuke Toba; Michihito Sasaki; Shinji Saito; Gabriel Gonzalez; William W. Hall; Hirofumi Sawa; Akihiko Sato; Yasuko Orba
    Journal of General Virology, 2026年11月05日
    研究論文(学術雑誌)
  • Integrated in vivo and transcriptomic analyses of lethal Oropouche virus infection reveal suppression of pathogenic host responses by antiviral therapy
    Cássia Sousa Moraes; Gabriel Gonzalez; Akihiko Sato; Shigeru Miki; Atsuko Inoue; Koshiro Tabata; Joshua W. Kranrod; Chilekwa Frances Kabamba; Aiko Ohnuma; Keita Matsuno; Rio Harada; Shinji Saito; Naoki Akimoto; Michihito Sasaki; Yasuko Orba; William W. Hall; Hirofumi Sawa; Yukari Itakura
    PLOS Pathogens, 2026年10月07日
    研究論文(学術雑誌)
  • West Nile virus capsid protein promotes viral replication and pathogenesis through PKCα-dependent lamin phosphorylation and nuclear deformation
    Keisuke Maezono; Passawat Thammahakin; Michiyo Kataoka; Tadaki Suzuki; Haruto Eguchi; Duong Thi Ngoc Thuy; Toshiro Yamaguchi; Akira Ota; Yukari Itakura; Koshiro Tabata; Hirofumi Sawa; Kentaro Yoshii; Hiroaki Kariwa; Shintaro Kobayashi
    2026年07月23日
  • NS4B and NS5 mutations expand the temperature range permissive for the replication of dual-host affiliated insect-specific flaviviruses in mosquito cells
    Hiroko Kobayashi; Koshiro Tabata; Michihito Sasaki; William W Hall; Hirofumi Sawa; Yasuko Orba
    Archives of Virology, 2026年03月
    研究論文(学術雑誌)
  • A lethal mouse model of Oz virus infection reveals hepatic involvement and enables evaluation of antiviral and vaccine efficacy
    Rio Harada; Cassia Sousa Moraes; Atsuko Inoue; Chilekwa Frances Kabamba; Koshiro Tabata; Motohito Goto; Riichi Takahashi; Joshua W. Kranrod; Shuichi Osawa; Aiko Ohnuma; Saito Shinji; Gabriel Gonzalez; Noriko Nagata; Mamoru Ito; Makoto Suematsu; Hideki Hasegawa; William W. Hall; Hirofumi Sawa; Yukari Itakura
    2026年01月29日
  • Tiled-Amplicon Whole-Genome Sequencing Method Reveals Endemic Circulation of Human Adenovirus Type 3 in Japan
    Gabriel Gonzalez; Naganori Nao; Koshiro Tabata; Yukari Itakura; Shinji Saito; Kenichiro Takahashi; Masaaki Kobayashi; Nobuyoshi Kitaichi; Nobuhisa Ishiguro; Tsuguto Fujimoto; Adriana E. Kajon; Hirofumi Sawa; Nozomu Hanaoka
    Viruses, 2026年01月05日
    研究論文(学術雑誌)
  • Development of a novel plate reader-based antibody-dependent enhancement (ADE) assay for orthoflavivirus infections
    Yannis Aklil; Hiroto Takeuchi; Gabriel Gonzalez; Atsuko Inoue; Kaito Maeda; Shintaro Kobayashi; Yukari Itakura; Shinji Saito; Anavaj Sakuntabhai; Michihito Sasaki; William W. Hall; Hirofumi Sawa; Yasuko Orba; Koshiro Tabata
    Journal of Virological Methods, 338, 115210, 115210, Elsevier BV, 2025年12月, [最終著者, 責任著者]
    研究論文(学術雑誌)
  • Application of the CPER reverse genetics system for genetic engineering of rabies virus
    Yukari Itakura; Nijiho Kawaguchi; Koshiro Tabata; Gabriel Gonzales; Kei Konishi; Aiko Ohnuma; Itsuko Furuta; Naoto Ito; Shinji Saito; William W. Hall; Yasuko Orba; Hirofumi Sawa; Michihito Sasaki
    2025年10月30日
  • Spatial gene expression analysis reveals pathological niches in Japanese encephalitis virus neuroinvasion.
    Yasuko Orba; Yukie Kashima; Koshiro Tabata; Yukari Itakura; Takuma Ariizumi; William W Hall; Hirofumi Sawa; Yutaka Suzuki; Michihito Sasaki
    Proceedings of the National Academy of Sciences of the United States of America, 122, 43, e2515006122, 2025年10月28日, [国際誌]
    英語, 研究論文(学術雑誌), Japanese encephalitis virus (JEV) infection causes encephalitis in humans and animals. Following intradermal infection, JEV crosses the blood-brain barrier (BBB) and reaches target cells in the brain parenchyma. However, the cellular dynamics and pathological niches involved in JEV neuroinvasion remain poorly understood. In this study, we investigated the early stages of JEV infection in the mouse brain employing a highly multiplexed spatial transcriptomics platform to map viral RNA and host gene expressions in intact brain sections at a single-cell resolution. Although JEV RNA was undetectable in brain sections at 1-day postinfection (dpi), innate immune responses were transiently activated across the brain. At 4 dpi, we detected limited viral RNA and mapped its spatial distribution, identifying glial cells surrounding microvessels as early targets of brain infection. We further characterized transcriptional changes in infected and surrounding bystander cells, revealing cell-type-specific antiviral responses. Notably, JEV neuroinvasion led to the downregulation of endothelial tight junction genes, indicative of an early event that precedes BBB impairment during subsequent disease progression. Our spatial transcriptomic analysis provides insights into cell-type- and region-specific responses to JEV infection, and highlights the early role of glial cells in shaping the immune response landscape of the brain. These findings greatly improve our understanding of JEV pathogenesis before the onset of clinical encephalitis.
  • Mosquito-borne alphaviruses in Zambia: isolation and characterization of Eilat and Sindbis viruses
    Chadwic De’Sean Mears; Koshiro Tabata; Takuma Ariizumi; Bernard M. Hang'ombe; Yongjin Qui; Hayato Harima; Masahiro Kajihara; William W. Hall; Michihito Sasaki; Hirofumi Sawa; Yasuko Orba
    Virus Research, 199604, 199604, Elsevier BV, 2025年07月
    研究論文(学術雑誌)
  • African lineage 1a West Nile virus isolated from crocodiles exhibits low neuroinvasiveness in mice.
    Hiroko Kobayashi; Herman Chambaro; Koshiro Tabata; Takuma Ariizumi; Wallaya Phongphaew; Kunda Ndashe; Joseph Ndebe; Paul Fandamu; Shintaro Kobayashi; Naoto Ito; Michihito Sasaki; Bernard M Hang'ombe; Edgar Simulundu; Yasuko Orba; Hirofumi Sawa
    The Journal of general virology, 105, 11, 2024年11月, [国際誌]
    英語, 研究論文(学術雑誌), West Nile virus (WNV) is a mosquito-borne flavivirus that causes encephalitis in humans and infects crocodiles, resulting in rashes and neurological signs. In Zambia, two distinct lineages of WNV have been detected in neighbouring areas: lineage 2 in mosquitoes and lineage 1a in farmed crocodiles. Considering the risk of direct or vector-mediated WNV transmission from crocodiles to mammals, it is necessary to elucidate the pathogenicity of WNV strains derived from crocodiles. In this study, WNV was successfully isolated from naturally infected farmed crocodiles (Croc110/2019/1/ZM, Croc110). We then investigated its proliferation and pathogenicity in mice in comparison with a WNV isolate from mosquitoes in Zambia (Zmq16) and two reference strains, including one highly pathogenic (NY99) and one low pathogenic (Eg101) strain. Although viral proliferation in Vero and mammalian neuronal cells was comparable among the strains, Croc110 exhibited low cell-to-cell transmission efficiency. In vivo, more than 70% of mice (C57BL/6) intracerebrally inoculated with Croc110 displayed neurological signs, and Croc110-infected mice exhibited similarly high mortality rates as NY99- and Zmq16-infected mice. Meanwhile, comparable virus growth was observed among the strains in the brain. However, the virulence of Croc110 was significantly lower than that of Zmq16 and NY99 following intradermal (ID) and intraperitoneal inoculation. Consistently, Croc110 displayed lower growth than Zmq16 and NY99 in the brain and peripheral tissues after ID inoculation. Our study revealed that the crocodile-derived WNV strain is less neuroinvasive in mice, and it exhibits distinct pathogenicity from the highly pathogenic mosquito-derived WNV strain circulating in Zambia.
  • A wide distribution of Beiji nairoviruses and related viruses in Ixodes ticks in Japan
    Mai Kishimoto; Yukari Itakura; Koshiro Tabata; Rika Komagome; Hiroki Yamaguchi; Kohei Ogasawara; Ryo Nakao; Yongjin Qiu; Kozue Sato; Hiroki Kawabata; Masahiro Kajihara; Naota Monma; Junji Seto; Asako Shigeno; Masayuki Horie; Michihito Sasaki; William W. Hall; Hirofumi Sawa; Yasuko Orba; Keita Matsuno
    Ticks and Tick-borne Diseases, 2024年11月, [筆頭著者]
    研究論文(学術雑誌)
  • Characterization of a mammalian orthoreovirus isolated from the large flying fox, Pteropus vampyrus, in Indonesia.
    Kittiya Intaruck; Koshiro Tabata; Yukari Itakura; Nijiho Kawaguchi; Mai Kishimoto; Agus Setiyono; Ekowati Handharyani; Hayato Harima; Takashi Kimura; William W Hall; Yasuko Orba; Hirofumi Sawa; Michihito Sasaki
    The Journal of general virology, 105, 9, 2024年09月, [国際誌]
    英語, 研究論文(学術雑誌), Fruit bats serve as an important reservoir for many zoonotic pathogens, including Nipah virus, Hendra virus, Marburg virus and Lyssavirus. To gain a deeper insight into the virological characteristics, pathogenicity and zoonotic potential of bat-borne viruses, recovery of infectious viruses from field samples is important. Here, we report the isolation and characterization of a mammalian orthoreovirus (MRV) from a large flying fox (Pteropus vampyrus) in Indonesia, which is the first detection of MRV in Southeast Asia. MRV was recovered from faecal samples of three different P. vampyrus in Central Java. Nucleotide sequence analysis revealed that the genome of the three MRV isolates shared more than 99% nucleotide sequence identity. We tentatively named one isolated strain as MRV12-52 for further analysis and characterization. Among 10 genome segments, MRV12-52 S1 and S4, which encode the cell-attachment protein and outer capsid protein, had 93.6 and 95.1% nucleotide sequence identities with known MRV strains, respectively. Meanwhile, the remaining genome segments of MRV12-52 were divergent with 72.9-80.7 % nucleotide sequence identities. Based on the nucleotide sequence of the S1 segment, MRV12-52 was grouped into serotype 2, and phylogenetic analysis demonstrated evidence of past reassortment events. In vitro characterization of MRV12-52 showed that the virus efficiently replicated in BHK-21, HEK293T and A549 cells. In addition, experimental infection of laboratory mice with MRV12-52 caused severe pneumonia with 75% mortality. This study highlights the presence of pathogenic MRV in Indonesia, which could serve as a potential animal and public health concern.
  • Increased production of orthoflavivirus single-round infectious particles produced in mammalian cells at a suboptimal culture temperature of 28°C
    Koshiro Tabata; Shintaro Kobayashi; Yukari Itakura; Gabriel Gonzalez; Chilekwa F. Kabamba; Shinji Saito; Michihito Sasaki; William W. Hall; Hirofumi Sawa; Yasuko Orba
    Journal of Virological Methods, 329, 115007, 115007, Elsevier BV, 2024年09月, [筆頭著者]
    研究論文(学術雑誌)
  • Establishment of a lethal mouse model of emerging tick-borne orthonairovirus infections.
    Takuma Ariizumi; Koshiro Tabata; Yukari Itakura; Hiroko Kobayashi; William W Hall; Michihito Sasaki; Hirofumi Sawa; Keita Matsuno; Yasuko Orba
    PLoS pathogens, 20, 3, e1012101, 2024年03月, [国際誌]
    英語, 研究論文(学術雑誌), Emerging and reemerging tick-borne virus infections caused by orthonairoviruses (family Nairoviridae), which are genetically distinct from Crimean-Congo hemorrhagic fever virus, have been recently reported in East Asia. Here, we have established a mouse infection model using type-I/II interferon receptor-knockout mice (AG129 mice) both for a better understanding of the pathogenesis of these infections and validation of antiviral agents using Yezo virus (YEZV), a novel orthonairovirus causing febrile illnesses associated with tick bites in Japan and China. YEZV-inoculated AG129 mice developed hepatitis with body weight loss and died by 6 days post infection. Blood biochemistry tests showed elevated liver enzyme levels, similar to YEZV-infected human patients. AG129 mice treated with favipiravir survived lethal YEZV infection, demonstrating the anti-YEZV effect of this drug. The present mouse model will help us better understand the pathogenicity of the emerging tick-borne orthonairoviruses and the development of specific antiviral agents for their treatment.
  • Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model.
    Michihito Sasaki; Tatsuki Sugi; Shun Iida; Yuichiro Hirata; Shinji Kusakabe; Kei Konishi; Yukari Itakura; Koshiro Tabata; Mai Kishimoto; Hiroko Kobayashi; Takuma Ariizumi; Kittiya Intaruck; Haruaki Nobori; Shinsuke Toba; Akihiko Sato; Keita Matsuno; Junya Yamagishi; Tadaki Suzuki; William W Hall; Yasuko Orba; Hirofumi Sawa
    EBioMedicine, 99, 104950, 104950, 2023年12月29日, [国際誌]
    英語, 研究論文(学術雑誌), BACKGROUND: Pulmonary infection with SARS-CoV-2 stimulates host immune responses and can also result in the progression of dysregulated and critical inflammation. Throughout the pandemic, the management and treatment of COVID-19 has been continuously updated with a range of antiviral drugs and immunomodulators. Monotherapy with oral antivirals has proven to be effective in the treatment of COVID-19. However, treatment should be initiated in the early stages of infection to ensure beneficial therapeutic outcomes, and there is still room for further consideration on therapeutic strategies using antivirals. METHODS: We studied the therapeutic effects of monotherapy with the oral antiviral ensitrelvir or the anti-inflammatory corticosteroid methylprednisolone and combination therapy with ensitrelvir and methylprednisolone in a delayed dosing model of hamsters infected with SARS-CoV-2. FINDINGS: Combination therapy with ensitrelvir and methylprednisolone improved respiratory conditions and reduced the development of pneumonia in hamsters even when the treatment was started after 2 days post-infection. The combination therapy led to a differential histological and transcriptomic pattern in comparison to either of the monotherapies, with reduced lung damage and down-regulation of expression of genes involved in the inflammatory response. Furthermore, we found that the combination treatment is effective in case of infection with either the highly pathogenic delta or circulating omicron variants. INTERPRETATION: Our results demonstrate the advantage of combination therapy with antiviral and corticosteroid drugs in COVID-19 treatment from the perspective of lung pathology and host inflammatory responses. FUNDING: Funding bodies are described in the Acknowledgments section.
  • 2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses.
    Kentaro Uemura; Haruaki Nobori; Akihiko Sato; Shinsuke Toba; Shinji Kusakabe; Michihito Sasaki; Koshiro Tabata; Keita Matsuno; Naoyoshi Maeda; Shiori Ito; Mayu Tanaka; Yuki Anraku; Shunsuke Kita; Mayumi Ishii; Kayoko Kanamitsu; Yasuko Orba; Yoshiharu Matsuura; William W Hall; Hirofumi Sawa; Hiroshi Kida; Akira Matsuda; Katsumi Maenaka
    Proceedings of the National Academy of Sciences of the United States of America, 120, 42, e2304139120, 2023年10月17日, [国際誌]
    英語, 研究論文(学術雑誌), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are causing significant morbidity and mortality worldwide. Furthermore, over 1 million cases of newly emerging or re-emerging viral infections, specifically dengue virus (DENV), are known to occur annually. Because no virus-specific and fully effective treatments against these or many other viruses have been approved, there is an urgent need for novel, effective therapeutic agents. Here, we identified 2-thiouridine (s2U) as a broad-spectrum antiviral ribonucleoside analogue that exhibited antiviral activity against several positive-sense single-stranded RNA (ssRNA+) viruses, such as DENV, SARS-CoV-2, and its variants of concern, including the currently circulating Omicron subvariants. s2U inhibits RNA synthesis catalyzed by viral RNA-dependent RNA polymerase, thereby reducing viral RNA replication, which improved the survival rate of mice infected with DENV2 or SARS-CoV-2 in our animal models. Our findings demonstrate that s2U is a potential broad-spectrum antiviral agent not only against DENV and SARS-CoV-2 but other ssRNA+ viruses.
  • Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain.
    Koshiro Tabata; Yukari Itakura; Takuma Ariizumi; Manabu Igarashi; Hiroko Kobayashi; Kittiya Intaruck; Mai Kishimoto; Shintaro Kobayashi; William W Hall; Michihito Sasaki; Hirofumi Sawa; Yasuko Orba
    Applied microbiology and biotechnology, 2023年10月13日, [筆頭著者], [国際誌]
    英語, 研究論文(学術雑誌), The most conserved fusion loop (FL) domain present in the flavivirus envelope protein has been reported as a dominant epitope for cross-reactive antibodies to mosquito-borne flaviviruses (MBFVs). As a result, establishing accurate serodiagnosis for MBFV infections has been difficult as anti-FL antibodies are induced by both natural infection and following vaccination. In this study, we modified the most conserved FL domain to overcome this cross-reactivity. We showed that the FL domain of lineage I insect-specific flavivirus (ISFV) has differences in antigenicity from those of MBFVs and lineage II ISFV and determined the key amino acid residues (G106, L107, or F108), which contribute to the antigenic difference. These mutations were subsequently introduced into subviral particles (SVPs) of dengue virus type 2 (DENV2), Zika virus (ZIKV), Japanese encephalitis virus (JEV), and West Nile virus (WNV). In indirect enzyme-linked immunosorbent assays (ELISAs), these SVP mutants when used as antigens reduced the binding of cross-reactive IgG and total Ig induced by infection of ZIKV, JEV, and WNV in mice and enabled the sensitive detection of virus-specific antibodies. Furthermore, immunization of ZIKV or JEV SVP mutants provoked the production of antibodies with lower cross-reactivity to heterologous MBFV antigens compared to immunization with the wild-type SVPs in mice. This study highlights the effectiveness of introducing mutations in the FL domain in MBFV SVPs with lineage I ISFV-derived amino acids to produce SVP antigens with low cross-reactivity and demonstrates an improvement in the accuracy of indirect ELISA-based serodiagnosis for MBFV infections. KEY POINTS: • The FL domain of Lineage I ISFV has a different antigenicity from that of MBFVs. • Mutated SVPs reduce the binding of cross-reactive antibodies in indirect ELISAs. • Inoculation of mutated SVPs induces antibodies with low cross-reactivity.
  • Unprecedented spike flexibility revealed by BSL3 Cryo-ET of active SARS-CoV-2 virions
    Hideo Fukuhara; Hisham M. Dokainish; Shunsuke Kita; Koshiro Tabata; Akira Takasu; Juha T. Huiskonen; Yuki Anraku; Toshiya Senda; David I. Stuart; Michihito Sasaki; Yasuko Orba; Yasuhiko Suzuki; Hirofumi Sawa; Katsumi Maenaka
    2023年10月11日
  • Impact of imprinted immunity induced by mRNA vaccination in an experimental animal model.
    Shigeru Fujita; Keiya Uriu; Lin Pan; Naganori Nao; Koshiro Tabata; Mai Kishimoto; Yukari Itakura; Hirofumi Sawa; Izumi Kida; Tomokazu Tamura; Takasuke Fukuhara; Jumpei Ito; Keita Matsuno; Kei Sato
    The Journal of infectious diseases, 2023年06月27日, [国際誌]
    英語, 研究論文(学術雑誌), The emergence of SARS-CoV-2 Omicron variants has led to concerns that ancestral SARS-CoV-2-based vaccines may not be effective against newly emerging Omicron subvariants. The concept of "imprinted immunity" suggests that individuals vaccinated with ancestral virus-based vaccines may not develop effective immunity against newly emerging Omicron subvariants, such as BQ.1.1 and XBB.1. Here, we investigated this possibility using hamsters. While natural infection induced effective antiviral immunity, breakthrough infections in hamsters with BQ.1.1 and XBB.1 Omicron subvariants after receiving the 3-dose mRNA-LNP vaccine resulted in only faintly induced humoral immunity, supporting the possibility of imprinted immunity.
  • Morphogenesis of Bullet-Shaped Rabies Virus Particles Regulated by TSG101
    Yukari Itakura; Koshiro Tabata; Takeshi Saito; Kittiya Intaruck; Nijiho Kawaguchi; Mai Kishimoto; Shiho Torii; Shintaro Kobayashi; Naoto Ito; Michiko Harada; Satoshi Inoue; Ken Maeda; Ayato Takada; William W. Hall; Yasuko Orba; Hirofumi Sawa; Michihito Sasaki
    Journal of Virology, 97, 5, e0043823, American Society for Microbiology, 2023年04月12日, [国際誌]
    英語, 研究論文(学術雑誌), Enveloped viruses bud from cells with the host lipid bilayer. Generally, the membrane modulation and abscission are mediated by host ESCRT complexes.
  • Isolation and Characterization of Distinct Rotavirus A in Bat and Rodent Hosts
    Mai Kishimoto; Masahiro Kajihara; Koshiro Tabata; Yukari Itakura; Shinsuke Toba; Seiya Ozono; Yuko Sato; Tadaki Suzuki; Naoto Ito; Katendi Changula; Yongjin Qiu; Akina Mori-Kajihara; Yoshiki Eto; Hayato Harima; Daniel Mwizabi; Bernard M. Hang’ombe; William W. Hall; Ayato Takada; Yasuko Orba; Hirofumi Sawa; Michihito Sasaki
    Journal of Virology, 97, 1, American Society for Microbiology, 2023年01月31日
    英語, 研究論文(学術雑誌), Recent advances in nucleotide sequence detection methods have enabled the detection of RVA genomes from various animals. These studies have discovered multiple divergent RVAs and have resulted in proposals for the genetic classification of novel genotypes.
  • S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters
    Michihito Sasaki; Koshiro Tabata; Mai Kishimoto; Yukari Itakura; Hiroko Kobayashi; Takuma Ariizumi; Kentaro Uemura; Shinsuke Toba; Shinji Kusakabe; Yuki Maruyama; Shun Iida; Noriko Nakajima; Tadaki Suzuki; Shinpei Yoshida; Haruaki Nobori; Takao Sanaki; Teruhisa Kato; Takao Shishido; William W. Hall; Yasuko Orba; Akihiko Sato; Hirofumi Sawa
    Science Translational Medicine, 15, 679, American Association for the Advancement of Science ({AAAS}), 2023年01月18日
    英語, 研究論文(学術雑誌)
  • Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant
    Akatsuki Saito; Tomokazu Tamura; Jiri Zahradnik; Sayaka Deguchi; Koshiro Tabata; Yuki Anraku; Izumi Kimura; Jumpei Ito; Daichi Yamasoba; Hesham Nasser; Mako Toyoda; Kayoko Nagata; Keiya Uriu; Yusuke Kosugi; Shigeru Fujita; Maya Shofa; Mst Monira Begum; Ryo Shimizu; Yoshitaka Oda; Rigel Suzuki; Hayato Ito; Naganori Nao; Lei Wang; Masumi Tsuda; Kumiko Yoshimatsu; Jin Kuramochi; Shunsuke Kita; Kaori Sasaki-Tabata; Hideo Fukuhara; Katsumi Maenaka; Yuki Yamamoto; Tetsuharu Nagamoto; Hiroyuki Asakura; Mami Nagashima; Kenji Sadamasu; Kazuhisa Yoshimura; Takamasa Ueno; Gideon Schreiber; Akifumi Takaori-Kondo; Kotaro Shirakawa; Hirofumi Sawa; Takashi Irie; Takao Hashiguchi; Kazuo Takayama; Keita Matsuno; Shinya Tanaka; Terumasa Ikeda; Takasuke Fukuhara; Kei Sato
    CELL HOST & MICROBE, 30, 9, 1540, +, 2022年09月, [筆頭著者]
    英語, 研究論文(学術雑誌)
  • Serological characterization of lineage II insect-specific flaviviruses compared with pathogenic mosquito-borne flaviviruses
    Koshiro Tabata; Yukari Itakura; Shinsuke Toba; Kentaro Uemura; Mai Kishimoto; Michihito Sasaki; Jessica J. Harrison; Akihiko Sato; William W. Hall; Roy A. Hall; Hirofumi Sawa; Yasuko Orba
    Biochemical and Biophysical Research Communications, 616, 115, 121, Elsevier {BV}, 2022年08月06日, [筆頭著者]
    英語, 研究論文(学術雑誌)
  • A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant)
    hirotaka minagawa; Hirofumi Sawa; Tomoko Fujita; Shintaro Kato; Asumi Inaguma; Miwako Hirose; Yasuko Orba; Michihito Sasaki; Koshiro Tabata; Naoki Nomura; Masashi Shingai; Yasuhiko Suzuki; Katsunori Horii
    Biochemical and Biophysical Research Communications, 614, 207, 212, Elsevier {BV}, 2022年07月
    英語, 研究論文(学術雑誌)
  • Glu333 in rabies virus glycoprotein is involved in virus attenuation through astrocyte infection and interferon responses
    Yukari Itakura; Koshiro Tabata; Kohei Morimoto; Naoto Ito; Herman M. Chambaro; Ryota Eguchi; Ken-ichi Otsuguro; William W. Hall; Yasuko Orba; Hirofumi Sawa; Michihito Sasaki
    iScience, 25, 4, 104122, 104122, Elsevier {BV}, 2022年04月
    英語, 研究論文(学術雑誌)
  • Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
    Michihito Sasaki; Mai Kishimoto; Yukari Itakura; Koshiro Tabata; Kittiya Intaruck; Kentaro Uemura; Shinsuke Toba; Takao Sanaki; Akihiko Sato; William W. Hall; Yasuko Orba; Hirofumi Sawa
    Biochemical and Biophysical Research Communications, 577, 146, 151, Elsevier {BV}, 2021年11月05日
    英語, 研究論文(学術雑誌)
  • Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses
    Osamu Kotani; Yasushi Suzuki; Shinji Saito; Akira Ainai; Akira Ueno; Takuya Hemmi; Kaori Sano; Koshiro Tabata; Masaru Yokoyama; Tadaki Suzuki; Hideki Hasegawa; Hironori Sato
    Viruses, 13, 9, 1733, 1733, {MDPI} {AG}, 2021年08月31日
    英語, 研究論文(学術雑誌), The stalk domain of influenza virus envelope glycoprotein hemagglutinin (HA) constitutes the axis connecting the head and transmembrane domains, and plays pivotal roles in conformational rearrangements of HA for virus infection. Here we characterized molecular interactions between the anti-HA stalk neutralization antibody F11 and influenza A(H1N1)pdm09 HA to understand the structural basis of the actions and modifications of this antibody. In silico structural analyses using a model of the trimeric HA ectodomain indicated that the F11 Fab fragment has physicochemical properties, allowing it to crosslink two HA monomers by binding to a region near the proteolytic cleavage site of the stalk domain. Interestingly, the F11 binding allosterically caused a marked suppression of the structural dynamics of the HA cleavage loop and flanking regions. Structure-guided mutagenesis of the F11 antibody revealed a critical residue in the F11 light chain for the F11-mediated neutralization. Finally, the mutagenesis led to identification of a unique F11 derivative that can neutralize both F11-sensitive and F11-resistant A(H1N1)pdm09 viruses. These results raise the possibility that F11 sterically and physically disturbs proteolytic cleavage of HA for the ordered conformational rearrangements and suggest that in silico guiding experiments can be useful to create anti-HA stalk antibodies with new phenotypes.
  • SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
    Michihito Sasaki; Shinsuke Toba; Yukari Itakura; Herman M. Chambaro; Mai Kishimoto; Koshiro Tabata; Kittiya Intaruck; Kentaro Uemura; Takao Sanaki; Akihiko Sato; William W. Hall; Yasuko Orba; Hirofumi Sawa
    mBio, 12, 4, e0141521, American Society for Microbiology, 2021年08月31日, [国際誌]
    英語, 研究論文(学術雑誌), SARS-CoV-2 uses its spike protein to enter target cells. The spike protein is cleaved by a host protease, and this event facilitates viral entry and broadens cell tropism.
  • Host Serine Proteases TMPRSS2 and TMPRSS11D Mediate Proteolytic Activation and Trypsin-Independent Infection in Group A Rotaviruses
    Michihito Sasaki; Yukari Itakura; Mai Kishimoto; Koshiro Tabata; Kentaro Uemura; Naoto Ito; Makoto Sugiyama; Christida E. Wastika; Yasuko Orba; Hirofumi Sawa
    Journal of Virology, 95, 11, American Society for Microbiology, 2021年05月10日, [国際誌]
    英語, 研究論文(学術雑誌), Proteolytic cleavage of the viral VP4 protein is essential for virion maturation and infectivity in group A rotaviruses (RVAs). In cell culture, RVAs are propagated in culture medium supplemented with the exogenous protease trypsin, which cleaves VP4 and induces the maturation of progeny RVA virions.
  • Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles
    Keisuke Maezono; Shintaro Kobayashi; Koshiro Tabata; Kentaro Yoshii; Hiroaki Kariwa
    Scientific Reports, 11, 1, Springer Science and Business Media {LLC}, 2021年04月28日
    英語, 研究論文(学術雑誌), AbstractWest Nile virus (WNV), a member of the Japanese encephalitis virus (JEV) serocomplex group, causes lethal encephalitis in humans and horses. Because serodiagnosis of WNV and JEV is hampered by cross-reactivity, the development of a simple, secure, and WNV-specific serodiagnostic system is required. The coexpression of prM protein and E protein leads to the secretion of subviral particles (SPs). Deletion of the C-terminal region of E protein is reported to affect the production of SPs by some flaviviruses. However, the influence of such a deletion on the properties and antigenicity of WNV E protein is unclear. We analyzed the properties of full-length E protein and E proteins lacking the C-terminal region as novel serodiagnostics for WNV infection. Deletion of the C-terminal region of E protein suppressed the formation of SPs but did not affect the production of E protein. The sensitivity of an enzyme-linked immunosorbent assay (ELISA) using the full-length E protein was higher than that using the truncated E proteins. Furthermore, in the ELISA using full-length E protein, there was little cross-reactivity with anti-JEV antibodies, and the sensitivity was similar to that of the neutralization test.
  • An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody
    Kaori Sano; Shinji Saito; Tadaki Suzuki; Osamu Kotani; Akira Ainai; Elly van Riet; Koshiro Tabata; Kumpei Saito; Yoshimasa Takahashi; Masaru Yokoyama; Hironori Sato; Takahiro Maruno; Kaede Usami; Susumu Uchiyama; Kiyoko Ogawa-Goto; Hideki Hasegawa
    PLOS ONE, 16, 1, Public Library of Science ({PLoS}), 2021年01月07日
    英語, 研究論文(学術雑誌), IgA antibodies, which are secreted onto the mucosal surface as secretory IgA antibodies (SIgAs), play an important role in preventing influenza virus infection. A recent study reported that anti-hemagglutinin (HA) head-targeting antibodies increase anti-viral functions such as hemagglutination inhibition (HI) and virus neutralization (NT), in addition to HA binding activity (reactivity) via IgA polymerization. However, the functional properties of anti-viral IgA antibodies with mechanisms of action distinct from those of anti-HA head-targeting antibodies remain elusive. Here, we characterized the functional properties of IgG, monomeric IgA, and polymeric IgA anti-HA stalk-binding clones F11 and FI6, and B12 (a low affinity anti-HA stalk clone), as well as Fab-deficient (ΔFab) IgA antibodies. We found that IgA polymerization impacts the functional properties of anti-HA stalk antibodies. Unlike anti-HA head antibodies, the anti-viral functions of anti-HA stalk antibodies were not simply enhanced by IgA polymerization. The data suggest that two modes of binding (Fab paratope-mediated binding to the HA stalk, and IgA Fc glycan-mediated binding to the HA receptor binding site (RBS)) occur during interaction between anti-stalk HA IgA antibodies and HA. In situations where Fab paratope-mediated binding to the HA stalk exceeded IgA Fc glycan-mediated binding to HA RBS, IgA polymerization increased anti-viral functions. By contrast, when IgA Fc glycan-mediated binding to the HA RBS was dominant, anti-viral activity will fall upon IgA polymerization. In summary, the results suggest that coordination between these two independent binding modules determines whether IgA polymerization has a negative or positive effect on the anti-viral functions of anti-HA stalk IgA antibodies.
  • Stereotyped B-cell response that counteracts antigenic variation of influenza viruses
    Keisuke Tonouchi; Yu Adachi; Saya Moriyama; Kaori Sano; Koshiro Tabata; Keigo Ide; Haruko Takeyama; Tadaki Suzuki; Yoshimasa Takahashi
    International Immunology, 32, 9, 613, 621, Oxford University Press ({OUP}), 2020年09月08日
    英語, 研究論文(学術雑誌), Abstract
    Influenza A subtypes are categorized into group 1 and group 2 based on the hemagglutinin (HA) sequence. Owing to the phylogenetic distance of HAs in different groups, antibodies that bind multiple HA subtypes across different groups are extremely rare. In this study, we demonstrated that an immunization with acid-treated HA antigen elicits germinal center (GC) B cells that bind multiple HA subtypes in both group 1 and group 2. The cross-group GC B cells utilized mostly one VH gene (1S56) and exhibited a sign of clonal evolution within GCs. The 1S56-lineage IgGs derived from GC B cells were able to bind to HA protein on the infected cell surface but not to the native form of HA protein, suggesting the cryptic nature of the 1S56 epitope and its exposure in infected cells. Finally, the 1S56-lineage IgGs provided protection against lethal infection in an Fc-dependent manner, independent of the virus-neutralizing activity. Thus, we identified 1S56-lineage antibodies as a unique stereotype for achieving cross-group influenza specificity. The antigens exposing the 1S56 epitope may be good candidates for broadly protective immunogens.
  • Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle
    Shiho Torii; Yasuko Orba; Michihito Sasaki; Koshiro Tabata; Yuji Wada; Michael Carr; Jody Hobson-Peters; Roy Hall; Ayato Takada; Takasuke Fukuhara; Yoshiharu Matsuura; William W. Hall; Hirofumi Sawa
    Journal of Biological Chemistry, 295, 23, 7941, 7957, Elsevier {BV}, 2020年06月
    英語, 研究論文(学術雑誌)
  • IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody
    Shinji Saito; Kaori Sano; Tadaki Suzuki; Akira Ainai; Yuki Taga; Tomonori Ueno; Koshiro Tabata; Kumpei Saito; Yuji Wada; Yuki Ohara; Haruko Takeyama; Takato Odagiri; Tsutomu Kageyama; Kiyoko Ogawa-Goto; Pretty Multihartina; Vivi Setiawaty; Krisna Pangesti; Hideki Hasegawa
    PLOS Pathogens, 15, 1, Public Library of Science ({PLoS}), 2019年01月03日
    英語, 研究論文(学術雑誌)
  • Shape-dependent adjuvanticity of nanoparticle-conjugated RNA adjuvants for intranasal inactivated influenza vaccines
    Taiyu Tazaki; Koshiro Tabata; Akira Ainai; Yuki Ohara; Shintaro Kobayashi; Takafumi Ninomiya; Yasuko Orba; Hideyuki Mitomo; Tetsuo Nakano; Hideki Hasegawa; Kuniharu Ijiro; Hirofumi Sawa; Tadaki Suzuki; Kenichi Niikura
    RSC Advances, 8, 30, 16527, 16536, Royal Society of Chemistry ({RSC}), 2018年
    英語, 研究論文(学術雑誌),

    Conjugation with gold nanorods enhanced the adjuvanticity of RNA adjuvant for intranasal inactivated influenza vaccines, providing efficient protection against infection in mice.

■ その他活動・業績
■ 主な担当授業
  • 一般教育演習(フレッシュマンセミナー), 2024年, 学士課程, 全学教育
■ 共同研究・競争的資金等の研究課題
  • 多種ウイルスに対するマルチプレックス中和試験法の開発
    科学研究費助成事業
    2025年04月01日 - 2028年03月31日
    田畑 耕史郎
    日本学術振興会, 若手研究, 北海道大学, 25K20567
  • 重症デング血漿漏出における血管周囲ニッチ破綻機構の解明と宿主標的治療戦略
    新興・再興感染症に対する革新的医薬品等開発推進研究事業
    2026年06月 - 2027年03月
    日本医療研究開発機構, 研究分担者
  • ADEを惹起しない次世代型デング熱ワクチンの開発
    研究奨励金
    2025年04月 - 2026年03月
    上原記念生命科学財団, 研究代表者
  • 新規ウイルス様粒⼦デザインコンセプトによるフラビウイルス感染 症ワクチンの研究開発
    ワクチン・新規モダリティ研究開発事業
    2024年04月 - 2026年03月
    ⽇本医療研究開発機構, 研究分担者
  • IgA抗体を用いた経鼻噴霧型ワクチンの新規DDS基盤技術の開発
    科学研究費助成事業
    2023年08月31日 - 2025年03月31日
    田畑 耕史郎
    日本学術振興会, 研究活動スタート支援, 北海道大学, 23K19580
  • 抗フラビウイルス抗体の結合プロファイルを用いたフラビウイルスの血清診断法の確立
    科学研究費助成事業
    2020年04月 - 2023年03月
    田畑 耕史郎
    本研究課題「抗フラビウイルス抗体の結合プロファイルを用いたフラビウイルスの血清診断法の確立」では、交叉反応性を含めた抗フラビウイルス抗体の結合活性を網羅的に評価することにより、ウイルス感染によって誘導される特徴的な抗体の結合プロファイルを見出し、これまでに感染歴のあるフラビウイルス種を特定することが可能な新規血清診断法の確立を目的としている。当該年度は、抗フラビウイルス抗体の結合プロファイル取得のためのウイルス抗原パネルの作製、及び作出した抗原パネルに対する標準感染血清の結合プロファイルを取得することを計画した。
    フラビウイルスタンパク質において、ウイルス種特異性が高いエピトープとして知られている二量体エンベロープタンパク質(Edimer)をウイルス抗原として使用するため、組換えタンパク質としての作出を試みてきた。これまでの検討により、Edimerは不安的なタンパク質であることから、作製および精製の過程で大部分が凝集してしまうことが明らかになった。
    フラビウイルスが感染した細胞から出芽までの過程で、pH依存的に粒子構造を変化させ、宿主のプロテアーゼであるフーリンによってエンベロープ前駆体タンパク質とエンベロープタンパク質(E)が消化されることにより、ウイルス粒子の成熟が進む。消化されたEはウイルス粒子上で、Edimerとして存在することが知られている。しかしながら、感染細胞から出芽するフラビウイルス粒子は部分的に成熟が進んだ未成熟粒子であることが示されている。そこで、精製したウイルス粒子をin vitroのフーリン消化実験を実施することにより、完全に成熟が進んだウイルス粒子を作出し、これを抗体検出抗原として用いることとした。
    当該年度以降は、完全成熟フラビウイルス粒子作出のための条件検討、また、標準感染血清を用いて完全成熟ウイルス粒子の抗体検出抗原としての有用性の評価を実施する。
    日本学術振興会, 特別研究員奨励費, 北海道大学, 20J22269